Fulgent Genetics, Inc.
FLGT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $84,069 | $81,803 | $73,463 | $76,214 |
| % Growth | 2.8% | 11.4% | -3.6% | – |
| Cost of Goods Sold | $48,557 | $47,368 | $45,117 | $44,365 |
| Gross Profit | $35,512 | $34,435 | $28,346 | $31,849 |
| % Margin | 42.2% | 42.1% | 38.6% | 41.8% |
| R&D Expenses | $13,860 | $13,480 | $12,395 | $12,113 |
| G&A Expenses | $23,335 | $26,392 | $25,291 | $24,341 |
| SG&A Expenses | $34,977 | $38,678 | $33,756 | $33,879 |
| Sales & Mktg Exp. | $11,642 | $12,286 | $8,465 | $9,538 |
| Other Operating Expenses | $2,025 | $1,990 | $1,990 | $1,992 |
| Operating Expenses | $50,862 | $54,148 | $48,141 | $47,984 |
| Operating Income | -$15,350 | -$19,713 | -$19,795 | -$16,135 |
| % Margin | -18.3% | -24.1% | -26.9% | -21.2% |
| Other Income/Exp. Net | $9,207 | -$1,806 | $8,072 | $8,090 |
| Pre-Tax Income | -$6,143 | -$21,519 | -$11,723 | -$8,045 |
| Tax Expense | $683 | -$2,263 | $176 | -$1,855 |
| Net Income | -$6,608 | -$18,957 | -$11,530 | -$5,888 |
| % Margin | -7.9% | -23.2% | -15.7% | -7.7% |
| EPS | -0.21 | -0.61 | -0.37 | -0.19 |
| % Growth | 65.6% | -64.9% | -94.7% | – |
| EPS Diluted | -0.21 | -0.61 | -0.37 | -0.19 |
| Weighted Avg Shares Out | 30,749 | 30,832 | 30,832 | 30,652 |
| Weighted Avg Shares Out Dil | 30,749 | 30,832 | 30,832 | 30,652 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7,874 | $8,091 | $8,018 | $8,293 |
| Interest Expense | $28 | $17 | $14 | $210 |
| Depreciation & Amortization | $6,038 | $6,054 | $5,919 | $6,192 |
| EBITDA | -$77 | -$15,448 | -$5,790 | -$9,943 |
| % Margin | -0.1% | -18.9% | -7.9% | -13% |